Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.832 SEK | +6.39% | +26.34% | -59.69% |
08/05 | Kancera AB Announces Executive Changes | CI |
03/05 | Kancera AB Reports Positive Results from the Clinical Phase I Study with KAND145 in Healthy Subjects | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.69% | 1.93Cr | |
+3.91% | 11TCr | |
+10.87% | 11TCr | |
-0.26% | 2.23TCr | |
-13.14% | 2.21TCr | |
-8.03% | 1.87TCr | |
-38.36% | 1.76TCr | |
-10.66% | 1.69TCr | |
+3.75% | 1.38TCr | |
+36.70% | 1.25TCr |
- Stock Market
- Equities
- KAN Stock
- News Kancera AB
- Kancera CEO Moves to Chief Scientific Officer Role; Successor Named